A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report

Int J Mol Sci. 2021 Aug 30;22(17):9410. doi: 10.3390/ijms22179410.

Abstract

Chronic lymphocytic leukemia (CLL) is considered a clonal B cell malignancy. Sporadically, CLL cases with multiple productive heavy and light-chain rearrangements were detected, thus leading to a bi- or oligoclonal CLL disease with leukemic cells originating either from different B cells or otherwise descending from secondary immunoglobulin rearrangement events. This suggests a potential role of clonal hematopoiesis or germline predisposition in these cases. During the screening of 75 CLL cases for kappa and lambda light-chain rearrangements, we could detect a single case with CLL cells expressing two distinct kappa and lambda light chains paired with two separate immunoglobulin heavy-chain variable regions. Furthermore, this patient also developed a prostate carcinoma. Targeted genome sequencing of highly purified light-chain specific CLL clones from this patient and from the prostate carcinoma revealed the presence of a rare germline polymorphism in the POLE gene. Hence, our data suggest that the detected SNP may predispose for cancer, particularly for CLL.

Keywords: POLE; case report; chronic lymphocytic leukemia; immunoglobulin light chain; prostate cancer.

Publication types

  • Case Reports

MeSH terms

  • Alternative Splicing*
  • DNA Polymerase II / genetics*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Male
  • Middle Aged
  • Poly-ADP-Ribose Binding Proteins / genetics*
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / pathology*

Substances

  • Poly-ADP-Ribose Binding Proteins
  • DNA Polymerase II
  • POLE protein, human